FDA Expands OTC Options for Opioid Overdose Reversal

(MedPage Today) -- The FDA approved another opioid overdose reversal product for over-the-counter (OTC) use, the agency announced on Tuesday.
The 4-mg intranasal naloxone hydrochloride (Rextovy) nasal spray joins other similar nonprescription...